Patients with major depressive disorder exhibit reduced reward size coding in the striatum

Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2017-10, Vol.79 (Pt B), p.317-323
Hauptverfasser: Takamura, Masahiro, Okamoto, Yasumasa, Okada, Go, Toki, Shigeru, Yamamoto, Tetsuya, Ichikawa, Naho, Mori, Asako, Minagawa, Hideaki, Takaishi, Yoshiyuki, Fujii, Yasutaka, Kaichi, Yoko, Akiyama, Yuji, Awai, Kazuo, Yamawaki, Shigeto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 323
container_issue Pt B
container_start_page 317
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 79
creator Takamura, Masahiro
Okamoto, Yasumasa
Okada, Go
Toki, Shigeru
Yamamoto, Tetsuya
Ichikawa, Naho
Mori, Asako
Minagawa, Hideaki
Takaishi, Yoshiyuki
Fujii, Yasutaka
Kaichi, Yoko
Akiyama, Yuji
Awai, Kazuo
Yamawaki, Shigeto
description Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted. Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI. In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms. Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients. •The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.
doi_str_mv 10.1016/j.pnpbp.2017.07.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1920199660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584617300660</els_id><sourcerecordid>1920199660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</originalsourceid><addsrcrecordid>eNp9kE9PGzEQxa0K1KS0n6BS5SOXhLF3Ge8eOFSIQqVIcIALF8trzzaOsn-wvUnLp8c00GOlkd4c3pvR-zH2VcBSgMCzzXLsx2ZcShBqCXkAP7C5qFS1KKXAIzYHmffzqsQZ-xTjBgBEAcVHNpOVgnOFOGePdyZ56lPke5_WvDObIXBHY6AY_Y6483EIjgKn32vf-MQDucmSy7o3wfHon4nbwfn-F_c9T2viMQVv0tR9Zset2Ub68qYn7OHH1f3lzWJ1e_3z8vtqYUso00JB3VamxbJum4bIIUrM9Qo0kmqJjVNKlgYLI5SULShSNYrK2VIa6wrRFifs9HB3DMPTRDHpzkdL263paZiiFnUmVNeIkK3FwWrDEGOgVo_Bdyb80QL0K1S90X-h6leoGvIA5tS3twdT05H7l3mnmA0XBwPlmjtPQUeboWZMPpBN2g3-vw9eAG8uilQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920199660</pqid></control><display><type>article</type><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</creator><creatorcontrib>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</creatorcontrib><description>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted. Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI. In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms. Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients. •The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2017.07.006</identifier><identifier>PMID: 28705766</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adult ; Anhedonia ; Anhedonia - drug effects ; Anhedonia - physiology ; Anticipation, Psychological - drug effects ; Anticipation, Psychological - physiology ; Antidepressive Agents, Second-Generation - therapeutic use ; Brain Mapping ; Citalopram - therapeutic use ; Corpus Striatum - diagnostic imaging ; Corpus Striatum - drug effects ; Corpus Striatum - physiopathology ; Depressive Disorder, Major - diagnostic imaging ; Depressive Disorder, Major - drug therapy ; Depressive Disorder, Major - physiopathology ; Depressive Disorder, Major - psychology ; Female ; fMRI ; Humans ; Magnetic Resonance Imaging ; Major depressive disorder ; Male ; Monetary incentive delay task ; Neuropsychological Tests ; Reaction Time ; Reward ; Serotonin Uptake Inhibitors - therapeutic use ; Striatum ; Treatment Outcome</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2017-10, Vol.79 (Pt B), p.317-323</ispartof><rights>2017 The Authors</rights><rights>Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</citedby><cites>FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</cites><orcidid>0000-0002-5039-2546</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2017.07.006$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28705766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takamura, Masahiro</creatorcontrib><creatorcontrib>Okamoto, Yasumasa</creatorcontrib><creatorcontrib>Okada, Go</creatorcontrib><creatorcontrib>Toki, Shigeru</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><creatorcontrib>Ichikawa, Naho</creatorcontrib><creatorcontrib>Mori, Asako</creatorcontrib><creatorcontrib>Minagawa, Hideaki</creatorcontrib><creatorcontrib>Takaishi, Yoshiyuki</creatorcontrib><creatorcontrib>Fujii, Yasutaka</creatorcontrib><creatorcontrib>Kaichi, Yoko</creatorcontrib><creatorcontrib>Akiyama, Yuji</creatorcontrib><creatorcontrib>Awai, Kazuo</creatorcontrib><creatorcontrib>Yamawaki, Shigeto</creatorcontrib><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted. Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI. In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms. Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients. •The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</description><subject>Adult</subject><subject>Anhedonia</subject><subject>Anhedonia - drug effects</subject><subject>Anhedonia - physiology</subject><subject>Anticipation, Psychological - drug effects</subject><subject>Anticipation, Psychological - physiology</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Brain Mapping</subject><subject>Citalopram - therapeutic use</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - physiopathology</subject><subject>Depressive Disorder, Major - diagnostic imaging</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Depressive Disorder, Major - physiopathology</subject><subject>Depressive Disorder, Major - psychology</subject><subject>Female</subject><subject>fMRI</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Major depressive disorder</subject><subject>Male</subject><subject>Monetary incentive delay task</subject><subject>Neuropsychological Tests</subject><subject>Reaction Time</subject><subject>Reward</subject><subject>Serotonin Uptake Inhibitors - therapeutic use</subject><subject>Striatum</subject><subject>Treatment Outcome</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9PGzEQxa0K1KS0n6BS5SOXhLF3Ge8eOFSIQqVIcIALF8trzzaOsn-wvUnLp8c00GOlkd4c3pvR-zH2VcBSgMCzzXLsx2ZcShBqCXkAP7C5qFS1KKXAIzYHmffzqsQZ-xTjBgBEAcVHNpOVgnOFOGePdyZ56lPke5_WvDObIXBHY6AY_Y6483EIjgKn32vf-MQDucmSy7o3wfHon4nbwfn-F_c9T2viMQVv0tR9Zset2Ub68qYn7OHH1f3lzWJ1e_3z8vtqYUso00JB3VamxbJum4bIIUrM9Qo0kmqJjVNKlgYLI5SULShSNYrK2VIa6wrRFifs9HB3DMPTRDHpzkdL263paZiiFnUmVNeIkK3FwWrDEGOgVo_Bdyb80QL0K1S90X-h6leoGvIA5tS3twdT05H7l3mnmA0XBwPlmjtPQUeboWZMPpBN2g3-vw9eAG8uilQ</recordid><startdate>20171003</startdate><enddate>20171003</enddate><creator>Takamura, Masahiro</creator><creator>Okamoto, Yasumasa</creator><creator>Okada, Go</creator><creator>Toki, Shigeru</creator><creator>Yamamoto, Tetsuya</creator><creator>Ichikawa, Naho</creator><creator>Mori, Asako</creator><creator>Minagawa, Hideaki</creator><creator>Takaishi, Yoshiyuki</creator><creator>Fujii, Yasutaka</creator><creator>Kaichi, Yoko</creator><creator>Akiyama, Yuji</creator><creator>Awai, Kazuo</creator><creator>Yamawaki, Shigeto</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5039-2546</orcidid></search><sort><creationdate>20171003</creationdate><title>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</title><author>Takamura, Masahiro ; Okamoto, Yasumasa ; Okada, Go ; Toki, Shigeru ; Yamamoto, Tetsuya ; Ichikawa, Naho ; Mori, Asako ; Minagawa, Hideaki ; Takaishi, Yoshiyuki ; Fujii, Yasutaka ; Kaichi, Yoko ; Akiyama, Yuji ; Awai, Kazuo ; Yamawaki, Shigeto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-709f8af649fbbeed662601636a2e926bd7724a63a1722f07e79618dc42acd31f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Anhedonia</topic><topic>Anhedonia - drug effects</topic><topic>Anhedonia - physiology</topic><topic>Anticipation, Psychological - drug effects</topic><topic>Anticipation, Psychological - physiology</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Brain Mapping</topic><topic>Citalopram - therapeutic use</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - physiopathology</topic><topic>Depressive Disorder, Major - diagnostic imaging</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Depressive Disorder, Major - physiopathology</topic><topic>Depressive Disorder, Major - psychology</topic><topic>Female</topic><topic>fMRI</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Major depressive disorder</topic><topic>Male</topic><topic>Monetary incentive delay task</topic><topic>Neuropsychological Tests</topic><topic>Reaction Time</topic><topic>Reward</topic><topic>Serotonin Uptake Inhibitors - therapeutic use</topic><topic>Striatum</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takamura, Masahiro</creatorcontrib><creatorcontrib>Okamoto, Yasumasa</creatorcontrib><creatorcontrib>Okada, Go</creatorcontrib><creatorcontrib>Toki, Shigeru</creatorcontrib><creatorcontrib>Yamamoto, Tetsuya</creatorcontrib><creatorcontrib>Ichikawa, Naho</creatorcontrib><creatorcontrib>Mori, Asako</creatorcontrib><creatorcontrib>Minagawa, Hideaki</creatorcontrib><creatorcontrib>Takaishi, Yoshiyuki</creatorcontrib><creatorcontrib>Fujii, Yasutaka</creatorcontrib><creatorcontrib>Kaichi, Yoko</creatorcontrib><creatorcontrib>Akiyama, Yuji</creatorcontrib><creatorcontrib>Awai, Kazuo</creatorcontrib><creatorcontrib>Yamawaki, Shigeto</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takamura, Masahiro</au><au>Okamoto, Yasumasa</au><au>Okada, Go</au><au>Toki, Shigeru</au><au>Yamamoto, Tetsuya</au><au>Ichikawa, Naho</au><au>Mori, Asako</au><au>Minagawa, Hideaki</au><au>Takaishi, Yoshiyuki</au><au>Fujii, Yasutaka</au><au>Kaichi, Yoko</au><au>Akiyama, Yuji</au><au>Awai, Kazuo</au><au>Yamawaki, Shigeto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients with major depressive disorder exhibit reduced reward size coding in the striatum</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2017-10-03</date><risdate>2017</risdate><volume>79</volume><issue>Pt B</issue><spage>317</spage><epage>323</epage><pages>317-323</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Anhedonia is a core symptom of major depressive disorder (MDD). While recent evidence suggests that reduced motivation for reward may be a core feature of anhedonia, the abnormalities in modulatory neural responses to variable reward amounts in MDD patients remain unclear. We investigated whether MDD patients' ability to represent variable-sized monetary rewards in the striatum is disrupted. Twelve MDD patients and 12 healthy volunteers completed an assessment of psychometric status and participated in a functional magnetic resonance imaging (fMRI) task that involved the anticipation of financial reward (monetary incentive delay task). The size of the monetary reward was varied among trial conditions and was cued with geometric stimuli. Patients participated in additional fMRI sessions after a 6-week pharmacological treatment with escitalopram, an SSRI. In healthy volunteers, striatal activity increased in proportion to the size of the monetary reward during reward anticipation. This pattern was altered in MDD patients, and significant group-by-reward size interaction effects were observed in the bilateral putamen and the left ventral striatum. Reward sensitivity in motor response and striatum activity at three regions were correlated in healthy controls. In MDD patients, this neurobehavioral coupling was not observed. In addition, changes in the neural reward sensitivity parameter at the left ventral striatum in response to treatment were positively correlated with a reduction of depressive symptoms. Patients with MDD exhibit reduced ability to modulate neural response when adjusting for variable amount of reward. This result suggests that reward size coding in the striatum may represent a neural correlate of motivational anhedonia in MDD patients. •The neural marker of motivational anhedonia in MDD is unclear.•Using an fMRI reward task, we measured neural reward sensitivity in MDD patients.•MDD patients showed reduced neural reward sensitivity in the striatum region.•Increased reward sensitivity and clinical response showed a positive relationship.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>28705766</pmid><doi>10.1016/j.pnpbp.2017.07.006</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5039-2546</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2017-10, Vol.79 (Pt B), p.317-323
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_1920199660
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Anhedonia
Anhedonia - drug effects
Anhedonia - physiology
Anticipation, Psychological - drug effects
Anticipation, Psychological - physiology
Antidepressive Agents, Second-Generation - therapeutic use
Brain Mapping
Citalopram - therapeutic use
Corpus Striatum - diagnostic imaging
Corpus Striatum - drug effects
Corpus Striatum - physiopathology
Depressive Disorder, Major - diagnostic imaging
Depressive Disorder, Major - drug therapy
Depressive Disorder, Major - physiopathology
Depressive Disorder, Major - psychology
Female
fMRI
Humans
Magnetic Resonance Imaging
Major depressive disorder
Male
Monetary incentive delay task
Neuropsychological Tests
Reaction Time
Reward
Serotonin Uptake Inhibitors - therapeutic use
Striatum
Treatment Outcome
title Patients with major depressive disorder exhibit reduced reward size coding in the striatum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T13%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%20with%20major%20depressive%20disorder%20exhibit%20reduced%20reward%20size%20coding%20in%20the%20striatum&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Takamura,%20Masahiro&rft.date=2017-10-03&rft.volume=79&rft.issue=Pt%20B&rft.spage=317&rft.epage=323&rft.pages=317-323&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2017.07.006&rft_dat=%3Cproquest_cross%3E1920199660%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920199660&rft_id=info:pmid/28705766&rft_els_id=S0278584617300660&rfr_iscdi=true